ROR2 and non-small cell lung carcinoma: In conclusion, expression of ROR2 and Wnt5a is significantly increased in NSCLC tissues and is associated with unfavorable prognosis, indicating that ROR2 and Wnt5a might be used as novel clinicopathological biomarkers to evaluate the prognosis of NSCLC.